Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Apr 12;13:896418. doi: 10.3389/fphar.2022.896418

Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years

Xiao-Ming He 1,2,, Min-Cong He 1,2,, Peng Yang 1,2, Qing-Wen Zhang 1,2, Zhen-Qiu Chen 3, Wei He 1,2,*, Qiu-Shi Wei 1,2,*
PMCID: PMC9039295  PMID: 35496305

In the published article, there is an error in the clinical trial registry number and the URL of Clinical Trial Registration. The correct Clinical Trial Registry details are “http://www.chictr.org.cn/showproj.aspx?proj=10829, ChiCTR-OPC-15007030”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES